{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:19:28Z","timestamp":1778501968640,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11046-021-00540-6","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T08:47:30Z","timestamp":1626338850000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment Outcome with Fosravuconazole for Onychomycosis"],"prefix":"10.1007","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-0192","authenticated-orcid":false,"given":"Harunari","family":"Shimoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Yo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"issue":"6","key":"540_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1203475417716362","volume":"21","author":"AK Gupta","year":"2017","unstructured":"Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525\u201339.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"540_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1067\/mjd.2000.104794","volume":"43","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians\u2019 offices: a multicenter Canadian survey of 15 000 patients. J Am Acad Dermatol. 2000;43(2):244\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"540_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1365-4362.1997.00163.x","volume":"36","author":"BE Elewski","year":"1997","unstructured":"Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol. 1997;36(10):754\u20136.","journal-title":"Int J Dermatol"},{"issue":"3","key":"540_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000469666","volume":"3","author":"J Wang","year":"2017","unstructured":"Wang J, Wiznia LE, Rieder EA. Patient-reported outcomes in onychomycosis: a review of psychometrically evaluated instruments in assessing treatment effectiveness. Skin Appendage Disord. 2017;3(3):144\u201355.","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"540_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/bjd.13358","volume":"171","author":"M Ameen","year":"2012","unstructured":"Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. British Association of Dermatologists\u2019 guidelines for the management of onychomycosis 2014. Br J Dermatol. 2012;171(5):937\u201358.","journal-title":"Br J Dermatol"},{"issue":"4","key":"540_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1439-0507.2006.01351.x","volume":"50","author":"C Seebacher","year":"2007","unstructured":"Seebacher C, Brasch J, Abeck D, Cornely O, Effendy I, Ginter-Hanselmayer G, et al. Onychomycosis. Mycoses. 2007;50(4):321\u20137.","journal-title":"Mycoses"},{"issue":"12","key":"540_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/1346-8138.15618","volume":"47","author":"T Mochizuki","year":"2020","unstructured":"Mochizuki T, Tsuboi R, Iozumi K, Ishizaki S, Ushigami T, Ogawa Y, et al. Guidelines for the management of dermatomycosis (2019). J Dermatol. 2020;47(12):1343\u201373.","journal-title":"J Dermatol"},{"issue":"8","key":"540_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/1346-8138.14935","volume":"46","author":"K Iozumi","year":"2019","unstructured":"Iozumi K, Abe M, Ito Y, Uesugi T, Onoduka T, Ichiro Kato I, et al. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: a multicenter, single-arm study. J Dermatol. 2019;46(8):641\u201351.","journal-title":"J Dermatol"},{"issue":"7","key":"540_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/1346-8138.13816","volume":"44","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Kishida H, Okubo A. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study. J Dermatol. 2017;44(7):753\u20139.","journal-title":"J Dermatol"},{"issue":"4","key":"540_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3314\/mmj.19-00009","volume":"60","author":"H Shimoyama","year":"2019","unstructured":"Shimoyama H, Kuwano Y, Sei Y. Retrospective survey of treatment outcomes of efinaconazole 10% solution and luliconazole 5% solution for onychomycosis in our facility. Med Mycol J. 2019;60(4):95\u2013100.","journal-title":"Med Mycol J"},{"issue":"4","key":"540_CR11","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.3314\/mmj.16-00006","volume":"57","author":"H Yamaguchi","year":"2016","unstructured":"Yamaguchi H. Potential of ravuconazole and its prodrugs as the new oral therapeutics for onychomycosis. Med Mycol J. 2016;57(4):E93\u2013110.","journal-title":"Med Mycol J"},{"issue":"4","key":"540_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1468-3083.2005.01212.x","volume":"19","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B. Ravuconazole Onychomycosis Group A phase I\/II randomized, doubleblind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis. J Eur Acad Dermatol Venereol. 2005;19(4):437\u201343.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"540_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/1346-8138.14607","volume":"45","author":"S Watanabe","year":"2018","unstructured":"Watanabe S, Tsubouchi I, Okubo A. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study. J Dermatol. 2018;45(10):1151\u20139.","journal-title":"J Dermatol"},{"issue":"8","key":"540_CR14","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1128\/AAC.48.8.3107-3111.2004","volume":"48","author":"M Cuenca-Estrella","year":"2004","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrob Agents Chemother. 2004;48(8):3107\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"540_CR15","doi-asserted-by":"publisher","unstructured":"Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kano R, Kubo M, et al. 2020 Fosravuconazole to treat severe onychomycosis in the elderly. J Dermatol doi: https:\/\/doi.org\/10.1111\/1346-8138.15651. Online ahead of print.","DOI":"10.1111\/1346-8138.15651"},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jaad.2010.06.034","volume":"66","author":"E Martinez-Herrera","year":"2012","unstructured":"Martinez-Herrera E, Moreno-Couti\u00f1o G, Fern\u00e1ndez-Mart\u00ednez RF, Finch J, Arenas R. Dermatophytoma: description of 7 cases. J Am Acad Dermatol. 2012;66:1014\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"540_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1067\/mjd.2002.124699","volume":"47","author":"CN Burkhart","year":"2002","unstructured":"Burkhart CN, Burkhart CG, Gupta AK. Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol. 2002;47(4):629\u201331.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"540_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jaad.2010.09.730","volume":"65","author":"RJ Hay","year":"2011","unstructured":"Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219\u201327.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"540_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3314\/mmj.19.007","volume":"60","author":"H Shimoyama","year":"2019","unstructured":"Shimoyama H, Sei Y. 2016 Epidemiological Survey of Dermatomycoses in Japan. Med Mycol J. 2019;60(3):75\u201382.","journal-title":"Med Mycol J"},{"issue":"4","key":"540_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00002512-200724040-00003","volume":"24","author":"DS Loo","year":"2007","unstructured":"Loo DS. Onychomycosis in the elderly: drug treatment options. Drugs Aging. 2007;24(4):293\u2013302.","journal-title":"Drugs Aging"},{"issue":"9","key":"540_CR21","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1111\/ijd.12832","volume":"54","author":"R Reszke","year":"2015","unstructured":"Reszke R, Pe\u0142ka D, Walasek A, Machaj Z, Reich A. Skin disorders in elderly subjects. Int J Dermatol. 2015;54(9):e332-338.","journal-title":"Int J Dermatol"},{"issue":"56","key":"540_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1365-2133.1999.00008.x","volume":"141","author":"B Sigurgeirsson","year":"1999","unstructured":"Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ, et al. LION Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis Lamisil versus Itraconazole in Onychomycosis. Br J Dermatol. 1999;141(56):5\u201314.","journal-title":"Br J Dermatol"},{"issue":"7","key":"540_CR23","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1111\/1346-8138.15374","volume":"47","author":"R Takeshima","year":"2020","unstructured":"Takeshima R, Asahina Y, Yaguchii T, Sato T. Tinea barbae due to Trichophyton rubrum successfully treated using oral fosravuconazole l-lysine ethanolate. J Dermatol. 2020;47(7):e254\u20135.","journal-title":"J Dermatol"},{"issue":"10","key":"540_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/1346-8138.15024","volume":"46","author":"H Noguchi","year":"2019","unstructured":"Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kano R, Yaguchi T, et al. Fungal melanonychia caused by Candida parapsilosis successfully treated with oral fosravuconazole. J Dermatol. 2019;46(10):911\u20133.","journal-title":"J Dermatol"},{"issue":"12","key":"540_CR25","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1111\/1346-8138.15033","volume":"46","author":"H Noguchi","year":"2019","unstructured":"Noguchi H, Matsumoto T, Hiruma M, Kimura U, Kano R, Yaguchi T, et al. Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole. J Dermatol. 2019;46(12):e446\u20137.","journal-title":"J Dermatol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-021-00540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-021-00540-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-021-00540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T08:47:32Z","timestamp":1626338852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-021-00540-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1007\/s11046-021-00540-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-210438\/v1","asserted-by":"object"}]},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent for publication was obtained from the study participant presented in Fig.\u00a0\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committees (Research Ethics Committee of Teikyo University; Tei-rin 18\u2013235-2) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}